Biocon
BSE: 532523 | NSE: BIOCON | ISIN: INE376G01013 | Pharmaceuticals
 |
Balance Sheet of Biocon |
------------------- in Rs. Cr. ------------------- |
| Mar '05 | Mar '06 | Mar '07 | Mar '08 | Mar '09 | ||||||
|
||||||||||
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||||||
|
||||||||||
| Sources Of Funds | ||||||||||
| Total Share Capital | 50.00 | 50.00 | 50.00 | 50.00 | 100.00 | |||||
| Equity Share Capital | 50.00 | 50.00 | 50.00 | 50.00 | 100.00 | |||||
| Share Application Money | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Preference Share Capital | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Reserves | 644.51 | 751.77 | 890.53 | 1,277.25 | 1,273.93 | |||||
| Revaluation Reserves | 1.43 | 1.27 | 1.11 | 0.95 | 0.95 | |||||
| Networth | 695.94 | 803.04 | 941.64 | 1,328.20 | 1,374.88 | |||||
| Secured Loans | 76.34 | 104.91 | 106.49 | 143.57 | 162.61 | |||||
| Unsecured Loans | 0.00 | 0.14 | 0.28 | 0.32 | 1.33 | |||||
| Total Debt | 76.34 | 105.05 | 106.77 | 143.89 | 163.94 | |||||
| Total Liabilities | 772.28 | 908.09 | 1,048.41 | 1,472.09 | 1,538.82 | |||||
| Mar '05 | Mar '06 | Mar '07 | Mar '08 | Mar '09 | ||||||
|
||||||||||
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||||||
|
||||||||||
| Application Of Funds | ||||||||||
| Gross Block | 270.20 | 316.11 | 861.19 | 880.11 | 987.50 | |||||
| Less: Accum. Depreciation | 65.37 | 88.29 | 145.00 | 200.65 | 273.33 | |||||
| Net Block | 204.83 | 227.82 | 716.19 | 679.46 | 714.17 | |||||
| Capital Work in Progress | 310.00 | 456.43 | 29.90 | 64.63 | 37.69 | |||||
| Investments | 223.73 | 139.06 | 78.60 | 477.26 | 346.69 | |||||
| Inventories | 71.29 | 105.31 | 150.66 | 167.74 | 194.52 | |||||
| Sundry Debtors | 172.88 | 206.04 | 274.85 | 225.66 | 310.17 | |||||
| Cash and Bank Balance | 1.99 | 0.38 | 4.63 | 4.91 | 5.29 | |||||
| Total Current Assets | 246.16 | 311.73 | 430.14 | 398.31 | 509.98 | |||||
| Loans and Advances | 38.10 | 21.21 | 46.78 | 123.55 | 266.27 | |||||
| Fixed Deposits | 1.43 | 1.63 | 3.00 | 3.21 | 0.76 | |||||
| Total CA, Loans & Advances | 285.69 | 334.57 | 479.92 | 525.07 | 777.01 | |||||
| Deffered Credit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Current Liabilities | 221.70 | 209.86 | 215.70 | 206.18 | 260.74 | |||||
| Provisions | 30.29 | 39.91 | 40.50 | 68.17 | 76.00 | |||||
| Total CL & Provisions | 251.99 | 249.77 | 256.20 | 274.35 | 336.74 | |||||
| Net Current Assets | 33.70 | 84.80 | 223.72 | 250.72 | 440.27 | |||||
| Miscellaneous Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Total Assets | 772.26 | 908.11 | 1,048.41 | 1,472.07 | 1,538.82 | |||||
|
||||||||||
| Contingent Liabilities | 125.88 | 70.49 | 144.98 | 146.17 | 173.88 | |||||
| Book Value (Rs) | 69.45 | 80.18 | 94.05 | 132.72 | 68.70 | |||||
| ||||||||||
| Source : Religare Technova | ||||||||||
| Explore Biocon connections | ||||||||||
| ||||||||||
